AEON Biopharma Inc (AMEX:AEON)’s traded shares stood at 665.17 million during the last session, with the company’s beta value hitting 0.16. At the close of trading, the stock’s price was $0.17, to imply an increase of 55.93% or $0.06 in intraday trading. The AEON share’s 52-week high remains $17.17, putting it -10000.0% down since that peak but still an impressive 41.18% since price per share fell to its 52-week low of $0.10. The company has a valuation of $13.66M, with an average of 21.78 million shares in intraday trading volume over the past 10 days and average of 3.67 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for AEON Biopharma Inc (AEON), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give AEON a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.18.
AEON Biopharma Inc (AMEX:AEON) trade information
After registering a 55.93% upside in the last session, AEON Biopharma Inc (AEON) has traded red over the past five days. The 5-day price performance for the stock is -10.10%, and -74.64% over 30 days. With these gigs, the year-to-date price performance is -68.35%. Short interest in AEON Biopharma Inc (AMEX:AEON) saw shorts transact 0.16 million shares and set a 1.6 days time to cover.
AEON Dividends
AEON Biopharma Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
AEON Biopharma Inc insiders hold 36.23% of total outstanding shares, with institutional holders owning 33.14% of the shares at 51.98% float percentage. In total, 33.14% institutions holds shares in the company.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the AEON Biopharma Inc (AEON) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 414.9 shares. This is just over 1.04% of the total shares, with a market valuation of $70906.0. Data from the same date shows that the other fund manager holds a little less at 320.9, or 0.80% of the shares, all valued at about 54841.0.
